Pelvic Floor Study: Biomechanical Properties of the Female Pelvic Floor
NCT ID: NCT01042470
Last Updated: 2020-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2010-01-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
female patients without pelvic organ prolapse, stage 0 or I (POP-Q)
No interventions assigned to this group
pelvic organ prolapse
female patients with pelvic organ prolapse stage II or higher (POP-Q)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with pelvic organ prolapse, i.e. cysto- or rectocele, uterine descensus
* postmenopausal women
Exclusion Criteria
* pregnancy / lactation
* current gynaecologic malignancies
* current malignancies of the pelvic floor
* infections such as HPV
* treatment with steroids or methotrexate
* no informed consent
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETH Zurich (Switzerland)
OTHER
University of Zurich
OTHER
David Scheiner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Scheiner
Oberarzt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David A Scheiner, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Zurich, Clinic for Gynaecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Zurich, Clinic for Gynaecology
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FHKUSZ11-2009
Identifier Type: -
Identifier Source: org_study_id